Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation

Leukemia and Lymphoma

Volumn 38, Issue 3-4, 2000, Pages 429-433

  Kanda, Yoshinobu ^a   Yamamoto, Rie ^a   Chizuka, Aki ^a   Suguro, Miyuki ^a   Hamaki, Tamae ^a   Matsuyama, Tomohiro ^a   Takezako, Naoki ^a   Miwa, Akiyoshi ^a   Togawa, Atsushi ^a   Kume, Masato ^a   Tsukuda, Masaaki ^a   Hasuo, Kanehiro ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Anticoagulation; Bone marrow transplantation; Deep vein thrombosis; Hypercoagulability; Vena caval filter

Indexed keywords

ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEPARIN; MELPHALAN; PREDNISOLONE; VINCRISTINE; WARFARIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTICOAGULATION; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DEVICE; FILTER; HUMAN; HUMAN CELL; HYPERGAMMAGLOBULINEMIA; LUNG EMBOLISM; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RASH; RISK FACTOR; SUPERIOR CAVA VEIN;

EID: 0034077155     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009087036     Document Type: Article

References (12)

1. Strasser, S.I., McDonald, G.B. (1998) Gastrointestinal and hepatic complications. In: Thomas ED, Blume KG, Forman SJ (ed.) Hematopoietic Cell Transplantation Blackwell Science: Massachusetts, pp627-658.
2. Sniecinski, I.J., O'Donnell, M.R. (1998) Hemolytic complications of hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (ed.) Hematopoietic Cell Transplantation Blackwell Science: Massachusetts, pp674-684.
3. Kearon, C., Ginsberg, J.S., Hirsh, J. (1998) Venus thromboembolic disease. In: Yusuf S, Cairns JA, Camm AJ, et al. (ed.) Evidence Based Cardiology BMJ Books: London, pp1009-1024.
4. Leblond, V., Salehian, B.D., Borel, C., et al. (1993) Alterations in natural anticoagulant levels during allogeneic hone marrow transplantation: a prospective study in 27 patients. Bone Marrow Transplantation 11, 299-305.
5. Faioni, E.M., Krachmalnicoff, A., Bearman, S.I., et al. (1993) Naturally occurring anticoagulants and hone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 81, 3458-3462.
6. Mortimer, J.E., Hewlett, J.S., Bay, J., Livingston, R.B. (1983) High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. Journal of Neurooncology 1, 269-273.
7. Hyers, T.M., Hull, R.D., Weg, J.G. (1995) Antithrombotic therapy for venous thromboembolic disease. Chest 108 (Suppl). 335S-351S.
8. Decousus, H., Leizorovicz, A., Parent, F. et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. New England Journal of Medicine 338, 409-415.
9. Ferris, E.J., McCowan, T.C., Carver, D.K., McFarland, D.R. (1993) Percutaneous interior vena caval filters: follow-up of seven designs in 320 patients. Radiology 188, 851-856.
10. Athanasouilis, C.A. (1993) Complications of vena caval filters. Radiology 188, 614-615.
11. Zwaan, M., Lorch, H., Kulke, C., et al. (1998) Clinical experiences with temporary vena caval filters. JVIR 9, 594-601.
12. Millward, S.F. (1998) Temporary and retrievable inferior vena cava filters: Current status. JVIR 9, 381-387.